Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer.

In this study we identified differential enrichment of pathways related to oxidative phosphorylation and RAS oncogene pathway in esophageal cancer patients with a favorable response to chemoradiation. Following further validation, our findings may portray potential surrogate signature of biomarkers based upon these pathways.